Contact VaxLiant:


Upcoming Events

Upcoming participation in 2017

Dr. Timothy Miller, PHD to speak at 48th AASV Annual Meeting on Sunday, February 26, 2017 at 4:00 pm

Effectively transitioning from vaccine research to commercial production. The adjuvanted DNA vaccine example from AgriLabs. 


VaxLiant provides innovative antigen-delivery systems and technical support that give companies the flexibility they need to develop and commercialize safe, effective vaccines. VaxLiant is a joint venture between two established companies: Benchmark Biolabs, Lincoln, Neb., which has provided streamlined research-to-commercialization services since 1996, and AgriLabs®, St. Joseph, Mo., a leader in marketing vaccines, nutritionals and other animal-health products for more than 25 years.


Return to our newsroom

Have specific research questions?

Contact us today for targeted research!